Glaukos
0 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Org chart
Thomas W. Burns
President & CEO
Thomas W. Burns
Collapse
Joseph E. Gilliam
President & COO
Jay L. Katz
Chief Medical Officer
Tomas Navratil
Chief Development Officer
Diane W. Biagianti
SVP & General Counsel
Chris M. Calcaterra
EVP, Global Commercial Operations
David S. Haffner
EVP, New Technologies
Jane E. Rady
SVP, Corporate Strategy & Business Development
Michele M. Allegretto
SVP, Human Resources
Matt Young
SVP, Global Operations
Alex R. Thurman
VP, Finance
Charles Kamen
Vice President, Chief Compliance Officer
Mike Neilon
Vice President
Chinmay Maheshwari
Vp, Drug Delivery & Innovation
Gabriella Szekely
VP, Research & Development, Combination Pharmaceutical Products
Robert Sanchez
Vp, Engineering, Anterior Segment Drug Delivery And Risk Management
John McLean
Global Head of Information Technology & Security
Cristina Minella
Global Head Talent Acquisition
Mark Rhein
Head Of Talent And Learning
Melissa Chaves
Sr. Director, Global Marketing Corneal Health
Brandy McCracken
Senior Director, Glaukos Patient Services
Paula B.
Director Reimbursement- Patient Support-patient Services
Cristina Sanchez Gonzalez
Marketing Director Europe, Middle East, India
Malaty Kittikhoun
Marketing Director, APAC
Cheyenne Arrowsling
Director, Global Field Service
Teams
View all
